8.95
price up icon0.11%   0.010
after-market Dopo l'orario di chiusura: 9.03 0.08 +0.89%
loading

Capricor Therapeutics Inc Borsa (CAPR) Ultime notizie

pulisher
Sep 30, 2026

CAPR Stock Jumps As Analysts Hike Price Targets Into FDA Date - StocksToTrade

Sep 30, 2026
pulisher
Sep 30, 2026

Capricor Therapeutics Stock Surges: What's Going On? - Benzinga

Sep 30, 2026
pulisher
Sep 30, 2026

CAPR Stock Pops As Analysts Hike Targets Ahead FDA Call - timothysykes.com

Sep 30, 2026
pulisher
Sep 30, 2026

CAPR Stock Jumps As Analysts Hike Price Targets Ahead FDA Call - StocksToTrade

Sep 30, 2026
pulisher
Sep 30, 2026

CAPR Stock Jumps As Analysts Hike Targets Ahead Of FDA Date - timothysykes.com

Sep 30, 2026
pulisher
Sep 30, 2026

CAPR Stock Jumps As Street Hikes Price Targets Into FDA Catalyst - StocksToTrade

Sep 30, 2026
pulisher
Sep 30, 2026

Capricor Therapeutics, Inc. stock Analysis: Bearish Trend and Intraday Pause - The Cryptonomist

Sep 30, 2026
pulisher
Sep 29, 2026

Capricor Therapeutics (CAPR) Shares Surge on Positive Phase 3 Da - GuruFocus

Sep 29, 2026
pulisher
Sep 29, 2026

Capricor jumps as study shows longer-term effects of deramiocel (CAPR:NASDAQ) - Seeking Alpha

Sep 29, 2026
pulisher
Sep 29, 2026

Why Did CAPR Stock Jump 20% After-Hours Today? - Yahoo Finance

Sep 29, 2026
pulisher
Sep 29, 2026

Total equity of Capricor Therapeutics, Inc. – HAN:4LN2 - TradingView

Sep 29, 2026
pulisher
Sep 28, 2026

Recover Investment Losses: Class Action Initiated Against Capricor Therapeutics, Inc. (CAPR) - ACCESS Newswire

Sep 28, 2026
pulisher
Sep 28, 2026

CAPR CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026 - Rutland Herald

Sep 28, 2026
pulisher
Sep 28, 2026

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law - Business Wire

Sep 28, 2026
pulisher
Sep 28, 2026

SueWallSt Reminds Capricor Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026CAPR - PR Newswire

Sep 28, 2026
pulisher
Sep 26, 2026

CAPR 2-DAY DEADLINE ALERT: Capricor Therapeutics, Inc. - GlobeNewswire

Sep 26, 2026
pulisher
Sep 26, 2026

CAPR 2-DAY DEADLINE ALERT: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28, 2026 Deadline - GlobeNewswire Inc.

Sep 26, 2026
pulisher
Sep 26, 2026

CAPR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026 - FinancialContent

Sep 26, 2026
pulisher
Sep 26, 2026

(CAPR) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Sep 26, 2026
pulisher
Sep 26, 2026

Class Action Lawsuit Filed: Capricor Therapeutics, Inc. (CAPR)Join by September 28, 2026Contact Levi & Korsinsky - ACCESS Newswire

Sep 26, 2026
pulisher
Sep 25, 2026

Kaplan Fox Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026 - The Globe and Mail

Sep 25, 2026
pulisher
Sep 25, 2026

Kaplan Fox Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026 | FinancialContent - FinancialContent

Sep 25, 2026
pulisher
Sep 25, 2026

Securities Fraud Class Action Filed Against Capricor Therapeutics, Inc. (CAPR)Levi & Korsinsky Reminds Investors of September 28, 2026 - ACCESS Newswire

Sep 25, 2026
pulisher
Sep 25, 2026

Levi & Korsinsky Notifies Capricor Therapeutics, Inc. (CAPR) InvestorsLead Plaintiff Deadline on September 28, 2026 - ACCESS Newswire

Sep 25, 2026
pulisher
Sep 25, 2026

Class Action Lawsuit Alert: Levi & Korsinsky Reminds Capricor Therapeutics, Inc. (CAPR) Investors of September 28, 2026 Deadline - ACCESS Newswire

Sep 25, 2026
pulisher
Sep 25, 2026

CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Sep 25, 2026
pulisher
Sep 25, 2026

CAPRICOR DEADLINE SEPTEMBER 28th: Bragar Eagel & Squire, - GlobeNewswire

Sep 25, 2026
pulisher
Sep 25, 2026

CAPR Stock On Track For Worst Week Ever After Regulatory Setback For DMD Therapy - Stocktwits

Sep 25, 2026
pulisher
Sep 25, 2026

Did You Lose Money on Capricor Therapeutics, Inc. (CAPR)? Levi & Korsinsky Urges Investors to Act Before September 28, 2026 - ACCESS Newswire

Sep 25, 2026
pulisher
Sep 25, 2026

Shareholders of Capricor Therapeutics, Inc. (CAPR): Protect Your Rights Before September 28, 2026Contact Levi & Korsinsky - ACCESS Newswire

Sep 25, 2026
pulisher
Sep 24, 2026

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - ACCESS Newswire

Sep 24, 2026
pulisher
Sep 24, 2026

Investors in Capricor Therapeutics, Inc. (CAPR): Protect Your RightsContact Levi & Korsinsky Before September 28, 2026 - ACCESS Newswire

Sep 24, 2026
pulisher
Sep 24, 2026

Kaplan Fox Announces a Securities Class Action Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR)Lead Plaintiff Deadline is September 28, 2026 - The Globe and Mail

Sep 24, 2026
pulisher
Sep 24, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesCAPR - PR Newswire

Sep 24, 2026
pulisher
Sep 24, 2026

September 28, 2026 Deadline Approaching: Join Class Action Against Capricor Therapeutics, Inc. (CAPR)Contact Levi & Korsinsky - ACCESS Newswire

Sep 24, 2026
pulisher
Sep 24, 2026

Levi & Korsinsky Notifies Capricor Therapeutics, Inc. (CAPR) Shareholders of Class Action Lawsuit and September 28, 2026 Deadline - ACCESS Newswire

Sep 24, 2026
pulisher
Sep 24, 2026

CAPR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Sep 24, 2026
pulisher
Sep 24, 2026

CAPR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review

Sep 24, 2026
pulisher
Sep 24, 2026

CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit - Morningstar

Sep 24, 2026
pulisher
Sep 24, 2026

Capricor Therapeutics Shareholder Alert: ClaimsFiler - GlobeNewswire

Sep 24, 2026
pulisher
Sep 24, 2026

Kaplan Fox Continues to Remind Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors of the Lead Plaintiff Deadline on September 28, 2026 - The Globe and Mail

Sep 24, 2026
pulisher
Sep 24, 2026

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire

Sep 24, 2026
pulisher
Sep 24, 2026

Contact Levi & Korsinsky by September 28, 2026 to Join Class Action Against Capricor Therapeutics, Inc. (CAPR) - ACCESS Newswire

Sep 24, 2026
pulisher
Sep 24, 2026

Lost Money on Capricor Therapeutics, Inc. (CAPR)? Join Class Action Before September 28, 2026Contact Levi & Korsinsky - ACCESS Newswire

Sep 24, 2026
pulisher
Sep 23, 2026

Capricor Therapeutics, Inc. (CAPR) Lawsuit – Investors Urged to Contact Levi & Korsinsky Before September 28, 2026 - ACCESS Newswire

Sep 23, 2026
pulisher
Sep 23, 2026

Levi & Korsinsky Urges Capricor Therapeutics, Inc. (CAPR) Shareholders to Act Before Lead Plaintiff Deadline September 28, 2026 - ACCESS Newswire

Sep 23, 2026
pulisher
Sep 23, 2026

Lost Money on Capricor Therapeutics, Inc. (CAPR)? Urged to Join Class Action Before September 28, 2026Contact Levi & Korsinsky - ACCESS Newswire

Sep 23, 2026
pulisher
Sep 23, 2026

Capricor Therapeutics, Inc. (CAPR) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 23, 2026
pulisher
Sep 23, 2026

Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on September 28, 2026 Against Capricor Therapeutics, Inc. (NASDAQ: CAPR) - FinancialContent

Sep 23, 2026
pulisher
Sep 23, 2026

CAPRICOR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class ActionCAPR - TMX Newsfile

Sep 23, 2026
pulisher
Sep 23, 2026

Securities Lawsuit Alert: Capricor Therapeutics, Inc. (CAPR) InvestorsContact Levi & Korsinsky Before September 28, 2026 - ACCESS Newswire

Sep 23, 2026
pulisher
Sep 23, 2026

CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics Securities LawsuitContact Levi & Korsinsky - Morningstar

Sep 23, 2026
pulisher
Sep 23, 2026

CAPR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026 - TMX Newsfile

Sep 23, 2026
pulisher
Sep 23, 2026

Capricor Therapeutics (CAPR) Stock Gets Fair Value Boost After Deramiocel Analyst Revisions - Yahoo Finance

Sep 23, 2026
pulisher
Sep 22, 2026

Capricor Therapeutics, Inc. (CAPR) LawsuitInvestors Urged to Contact Levi & Korsinsky Before September 28, 2026 - ACCESS Newswire

Sep 22, 2026
pulisher
Sep 22, 2026

Capricor Therapeutics, Inc. Notice of September 28, 2026 - GlobeNewswire

Sep 22, 2026
pulisher
Sep 22, 2026

Kaplan Fox Continues to Alert Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Class Action Deadline on September 28, 2026 - NewMediaWire

Sep 22, 2026
pulisher
Sep 22, 2026

CAPRICOR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire

Sep 22, 2026
pulisher
Sep 22, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CAPR - FinancialContent

Sep 22, 2026
pulisher
Sep 22, 2026

Portnoy Law Firm Announces Class Action on Behalf of Capricor Therapeutics, Inc. Investors - lincolnjournal.com

Sep 22, 2026
pulisher
Sep 22, 2026

CAPR LAWSUIT ALERT: Levi & Korsinsky Notifies Capricor Therapeutics, Inc. InvestorsLead Plaintiff Deadline September 28, 2026 - ACCESS Newswire

Sep 22, 2026
$96.90
price up icon 0.05%
$57.16
price down icon 0.82%
$35.72
price up icon 0.62%
$219.72
price down icon 4.96%
ONC ONC
$358.07
price down icon 0.20%
$206.64
price up icon 0.36%
Capitalizzazione:     |  Volume (24 ore):